•
Sep 30, 2012

Edwards Lifesciences Q3 2012 Earnings Report

Total Revenue
$448M
Previous year: $413M
+8.5%
EPS
$0.1
Previous year: $0.15
-33.3%
Gross Profit
$336M
Previous year: $287M
+17.1%
Cash and Equivalents
$306M
Previous year: $244M
+25.3%
Total Assets
$2.2B
Previous year: $1.98B
+10.7%

Edwards Lifesciences

Edwards Lifesciences